Results for tag: "Cardiotoxicity"

Cardiotoxicity is a term used to describe the potential of a drug or other substance to cause damage to the heart. Cardiovascular drugs are a class of drugs used to treat conditions related to the heart and blood vessels, such as high blood pressure, coronary artery disease, and congestive heart failure. Cardiotoxicity is a major concern for these drugs, as it can lead to serious side effects, including arrhythmias, heart failure, and even death. The cardiotoxicity market is a subset of the cardiovascular drugs market, and focuses on the development of drugs and other treatments that reduce the risk of cardiotoxicity. This includes the development of new drugs, as well as the development of safer formulations of existing drugs. Additionally, research is being conducted into the use of biomarkers to identify patients at risk of cardiotoxicity, as well as the use of genetic testing to identify patients who may be more susceptible to cardiotoxicity. Some companies in the cardiotoxicity market include AstraZeneca, Pfizer, Merck, and Novartis. Show Less Read more